Understanding Oculocutaneous Albinism Type 2 (OCA2)
Last updated:
Oculocutaneous Albinism Type 2 (OCA2) is a manageable genetic condition that reduces melanin in the skin, hair, and eyes. While it causes vision challenges and requires strict sun protection to prevent skin cancer, individuals with OCA2 have normal intelligence and a normal life expectancy.
Key Takeaways
- • OCA2 is caused by a genetic mutation that reduces the body's ability to produce melanin, the pigment that colors the skin, hair, and eyes.
- • The condition primarily impacts vision, frequently causing reduced visual acuity, light sensitivity, and involuntary eye movements.
- • People with OCA2 have a normal life expectancy but face a significantly higher risk of skin cancer without strict, consistent sun protection.
- • Isolated OCA2 does not affect a person's intelligence, cognitive development, or ability to learn.
- • Routine skin screenings with a dermatologist and low vision accommodations are essential parts of managing OCA2 throughout life.
Receiving a diagnosis of Oculocutaneous Albinism Type 2 (OCA2) for yourself or your child can feel overwhelming, but it is important to know that this is a manageable genetic condition [1]. While it changes how the body produces pigment, it does not define your or your child’s potential or future [2]. With proactive care for the eyes and skin, individuals with OCA2 grow up to live full, healthy, and successful lives [2].
What is OCA2?
OCA2 is a genetic condition that results in reduced production of melanin, the natural pigment that gives color to the skin, hair, and eyes [1]. It is caused by a change (mutation) in the OCA2 gene (formerly called the P gene) located on chromosome 15 [1][3]. This gene provides instructions for a protein that helps regulate the environment where melanin is made [1]. Without enough of this protein, the body cannot produce normal amounts of pigment [4]. You can learn more about this in our section on The Genetics and Biology of OCA2.
How Common is OCA2?
OCA2 is one of the most common forms of albinism globally [2]. While it affects people of all backgrounds, it is especially prevalent in Sub-Saharan Africa [2][5]:
- Global Average: Roughly 1 in 36,000 people in European and White American populations [2].
- Sub-Saharan Africa: The prevalence is much higher, estimated at 1 in 3,900 in South Africa and as high as 1 in 1,100 among the Ibo people of Nigeria [2].
- Regional Variants: In many African nations, a specific genetic change known as the 2.7 kb deletion is the most frequent cause of OCA2 [6][7].
The Three Main Areas of Impact
The lack of melanin primarily affects three parts of the body, which you can read about in detail in our Symptoms and Ocular Signs guide:
- Eyes: Melanin is vital for the development of the retina (the back of the eye) before birth [8]. Most people with OCA2 have reduced visual acuity (blurriness), nystagmus (involuntary eye movements), and photophobia (sensitivity to bright light) [2][9].
- Skin: Because melanin protects the skin from the sun’s ultraviolet (UV) rays, people with OCA2 have very sensitive skin that burns easily [10].
- Hair: Hair color can range from very light blond to golden or even light brown, depending on how much residual pigment the body is able to produce [2].
Life Expectancy and Health
It is a common misunderstanding that albinism itself shortens life. OCA2 is not a fatal condition. People with OCA2 have a normal life expectancy as long as their skin is protected from the sun [2].
The primary health risk for individuals with OCA2 is skin cancer, specifically squamous cell carcinoma [10][11]. In regions with high sun intensity, the risk of developing these cancers is significantly higher due to chronic sun exposure without sufficient melanin protection [10][12]. However, this risk is highly preventable through consistent sun protection and routine screenings, detailed in our Protecting Skin Health guide.
Common Misunderstandings
- Intelligence: There is no evidence that isolated OCA2 affects a person’s intelligence or cognitive development [13][14]. Any challenges in school or work are typically related to vision, not learning ability [2].
- Contagion: Albinism is strictly genetic; it is not contagious and cannot be ‘caught’ [2].
- Syndromes: In very rare cases, OCA2 can be part of a larger genetic deletion that includes other conditions, which do involve developmental delays [15][16]. Your doctor can confirm if you or your child has ‘isolated’ OCA2 through appropriate testing, as outlined in Getting an Accurate Diagnosis.
For guidance on navigating daily life, school, and work, explore our guide on Living with OCA2: Psychosocial Support and Daily Life.
Frequently Asked Questions
Does Oculocutaneous Albinism Type 2 (OCA2) affect life expectancy?
Will OCA2 affect my child's intelligence or ability to learn?
Why does OCA2 cause vision problems?
What are the main health risks associated with OCA2?
Questions for Your Doctor
- • What specific mutation was found in the OCA2 gene (e.g., the 2.7 kb deletion)?
- • Have you ruled out other conditions like Angelman or Prader-Willi syndrome that can sometimes look like OCA2 at first?
- • What is the grade of foveal hypoplasia, and what does that mean for future vision?
- • Can you provide a 'Low Vision' referral to help with school or workplace accommodations like high-contrast materials or special seating?
- • How often should a complete skin examination with a dermatologist be scheduled?
Questions for You
- • What are my biggest fears about this diagnosis, and have I shared them with my healthcare team?
- • Do we have a reliable way to get high-SPF sunscreen and UV-protective clothing?
- • How can I best explain OCA2 to family members, teachers, or coworkers to ensure support and inclusion?
- • Have I noticed any changes in my or my child's skin, like new spots or sores that don't heal?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Oculocutaneous albinism in a patient with an OCA2 variant: molecular and clinical insights.
Neissi M, Al-Mozani SK, Al-Zaalan AR, et al.
Asian biomedicine : research, reviews and news 2025; (19(3)):154-163 doi:10.2478/abm-2025-0019.
PMID: 40735666 - 2
[A case for the inclusion of oculocutaneous albinism as a skin-related Neglected Tropical Disease].
Aquaron R, Lund P, Baker C
Medecine tropicale et sante internationale 2023; (3(4)) doi:10.48327/mtsi.v3i4.2023.434.
PMID: 38390024 - 3
Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism.
Ma L, Zhu J, Wang J, et al.
Frontiers in genetics 2021; (12()):715437 doi:10.3389/fgene.2021.715437.
PMID: 34707637 - 4
SLC45A2 protein stability and regulation of melanosome pH determine melanocyte pigmentation.
Le L, Escobar IE, Ho T, et al.
Molecular biology of the cell 2020; (31(24)):2687-2702 doi:10.1091/mbc.E20-03-0200.
PMID: 32966160 - 5
Albinism: from genetics to cell biology and physiopathology.
Diallo M, Salavessa L, Arveiler B, Delevoye C
Presse medicale (Paris, France : 1983) 2025; (55(3)):104333 doi:10.1016/j.lpm.2025.104333.
PMID: 41314540 - 6
Molecular genetic characterization of Congolese patients with oculocutaneous albinism.
Laetitia MM, Veronique K, Mamy NZ, et al.
European journal of medical genetics 2022; (65(11)):104611 doi:10.1016/j.ejmg.2022.104611.
PMID: 36116698 - 7
TYPES OF ALBINISM IN THE BLACK SOUTHERN AFRICA POPULATION.
Kromberg JG, Bothwell J, Kidson SH, et al.
East African medical journal 2012; (89(1)):20-7.
PMID: 26845807 - 8
Ocular findings and a comparative study of hair, skin and iris color in Chinese patients with albinism.
Arcot Sadagopan K, Teng CH, Hui G, Lin DL
Ophthalmic genetics 2023; (44(1)):54-69 doi:10.1080/13816810.2022.2135109.
PMID: 36316991 - 9
Identification of 12 OCA Cases in Chinese Population and Two Novel Variants.
Zhong Z, Zhou Z, Chen J, Zhang J
Frontiers in genetics 2022; (13()):926511 doi:10.3389/fgene.2022.926511.
PMID: 35923705 - 10
Oculocutaneous Albinism and Squamous Cell Carcinoma of the Skin of the Head and Neck in Sub-Saharan Africa.
Lekalakala PT, Khammissa RA, Kramer B, et al.
Journal of skin cancer 2015; (2015()):167847 doi:10.1155/2015/167847.
PMID: 26347819 - 11
Clinico-pathologic profile of skin cancers in oculocutaneous albinism at Universitas Academic Hospital.
Makuru MH, Maruma F, Ngwenya E, Mponda K
Health SA = SA Gesondheid 2025; (30()):2906 doi:10.4102/hsag.v30i0.2906.
PMID: 40357250 - 12
"Exploring the intersection of albinism and Trichilemmal carcinoma: A case of bilateral trichilemmal carcinoma in the axilla".
Dfallah MA, Elamin AM, Gerib MA, et al.
International journal of surgery case reports 2025; (128()):110926 doi:10.1016/j.ijscr.2025.110926.
PMID: 39961174 - 13
Sentinel Nystagmus: The Key to Identifying Type II Oculocutaneous Albinism (OCA2) in the Pediatric Setting.
Niknam J, Petrosyan A, Agustin V, Shoubaki A
Case reports in pediatrics 2026; (2026()):5514931 doi:10.1155/crpe/5514931.
PMID: 41523963 - 14
Foveal Hypoplasia in a Child With Tyrosinase-Positive Albinism.
Kavalaraki A, Paraskevopoulos K, Kavalaraki M, et al.
Cureus 2023; (15(9)):e44558 doi:10.7759/cureus.44558.
PMID: 37790023 - 15
[Clinical and molecular genetic analysis of Angelman syndrome with oculocutaneous albinism type 2: A case report and literature review].
Zhou QJ, Gong P, Jiao XR, Yang ZX
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2023; (55(1)):181-185.
PMID: 36718709 - 16
Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation.
Delahanty RJ, Zhang Y, Bichell TJ, et al.
Cell reports 2016; (17(12)):3115-3124 doi:10.1016/j.celrep.2016.11.067.
PMID: 28009282
This page provides educational information about Oculocutaneous Albinism Type 2 (OCA2). It is not a substitute for professional medical advice, diagnosis, or treatment from your geneticist, ophthalmologist, or dermatologist.
Stay up to date
Get notified when new research about Oculocutaneous albinism type 2 is published.
No spam. Unsubscribe anytime.